83 FR 9325 - Agency Information Collection Request; 60-Day Public Comment Request
DEPARTMENT OF HEALTH AND HUMAN SERVICES Federal Register Volume 83, Issue 43 (March 5, 2018)
Federal Register Volume 83, Issue 43 (March 5, 2018)
| Page Range | 9325-9326 | |
| FR Document | 2018-04386 |
[Federal Register Volume 83, Number 43 (Monday, March 5, 2018)] [Notices] [Pages 9325-9326] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2018-04386] ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES [Document Identifier OS-0990-New] Agency Information Collection Request; 60-Day Public Comment Request AGENCY: Office of the Secretary, HHS. ACTION: Notice. ----------------------------------------------------------------------- SUMMARY: In compliance with the requirement of the Paperwork Reduction Act of 1995, the Office of the Secretary (OS), Department of Health and Human Services, is publishing the following summary of a proposed collection for public comment. DATES: Comments on the ICR must be received on or before May 4, 2018. ADDRESSES: Submit your comments to [email protected] or by calling 202-795-7714. FOR FURTHER INFORMATION CONTACT: When submitting comments or requesting information, please include the document identifier 0990-New-60D and project title for reference to [email protected] or call the Reports Clearance Officer. SUPPLEMENTARY INFORMATION: Interested persons are invited to send comments regarding this burden estimate or any other aspect of this collection of information, including any of the following subjects: (1) The necessity and utility of the proposed information collection for the proper performance of the agency's functions; (2) the accuracy of the estimated burden; (3) ways to enhance the quality, utility, and clarity of the information to be collected; and (4) the use of automated collection techniques or other forms of information technology to minimize the information collection burden. Title of the Collection: Trafficking Victim Assistance Program Social Network Analysis--Network Survey. Type of Collection: New. OMB No. 0990-NEW-Office of the Assistant Secretary for Planning and Evaluation-Administration for Children and Families' Trafficking Victim Assistance Program Abstract The Office of the Assistant Secretary for Planning and Evaluation (ASPE), in partnership with the Administration for Children and Families (ACF), U.S. Department of Health and Human Services (HHS) is requesting Office of Management and Budget (OMB) approval for a new information collection request, ``Trafficking Victim Assistance Program (TVAP) Network Survey.'' ICF has been contracted to carry out this project under the guidance of ASPE and ACF. TVAP, as authorized by the Trafficking Victims Protection Act of 2000, provides comprehensive case management services to foreign-born victims of human trafficking residing in the United States. Since its inception, TVAP funding and infrastructure have remained relatively unchanged: Services are paid on a per capita basis, and funds are managed through three primary grantees that enter into cooperative agreements with service providers (subrecipients). Given the changing landscape and the greater understanding of the nature and extent of trafficking, HHS is undertaking a program assessment to understand whether any efficiencies can be gained in the program administration and structure. Building on an earlier fiscal year 2018 assessment to solicit qualitative feedback from a range of program stakeholders, the information collected for this program survey aims to help HHS determine if efficiencies can be [[Page 9326]] gained through improved coordination among TVAP grantees, TVAP subrecipients, and other service providers. The data collected and analyzed under this submission will help HHS better understand the type and extent of the relationships between the TVAP grantees, TVAP subrecipients, and other service providers operating in TVAP subrecipient areas. This information will enable HHS to understand the structure of the grantee/subrecipient network and inform recommendations for more efficient network management and distribution of support. Data will be collected through an electronic survey of fiscal year 2016 TVAP grantees and subrecipients. Key staff at grantee sites and subrecipient organizations will complete a self-administered online survey that will include questions for each respondent about services for which referrals are made, estimated costs of services, service coordination between grantees or subrecipients, and type and strength of relationships between grantees and subrecipients. With this data, ICFwill build a social/organizational network for HHS to depict how grantee and subrecipient organizations collaborate with one another through TVAP to better understand the existing network and identify potential opportunities for improving the efficiency of the network. ASPE anticipates completion of all data collection activities by October 2018. Annualized Burden Hour Table ---------------------------------------------------------------------------------------------------------------- Number of Average Forms Respondents Number of responses per burden per Total burden respondents respondents response hours ---------------------------------------------------------------------------------------------------------------- TVAP Network Survey........... TVAP grantees... 3 1 45/60 2.25 TVAP Network Survey........... TVAP 253 1 45/60 189.75 subrecipients. --------------------------------------------------------------- Total..................... ................ 256 .............. .............. 192 ---------------------------------------------------------------------------------------------------------------- Terry S. Clark, Office of the Secretary, Paperwork Reduction Act Reports Clearance Officer. [FR Doc. 2018-04386 Filed 3-2-18; 8:45 am] BILLING CODE 4150-05-P
![Federal Register / Vol. 83, No. 43 / Monday, March 5, 2018 / Notices 9325
and/or go to the Dockets Management fumarate); ODEFSEY (emtricitabine, the document identifier 0990–New–60D
Staff, 5630 Fishers Lane, Rm. 1061, rilpivirine, tenofovir alafenamide) and project title for reference to
Rockville, MD 20852. 4. EMEND (aprepitant) capsule and Sherrette.funn@hhs.gov or call the
FOR FURTHER INFORMATION CONTACT: oral suspension Reports Clearance Officer.
Kenneth Quinto, Office of the 5. EPIDUO FORTE (adapalene/ SUPPLEMENTARY INFORMATION: Interested
Commissioner, Food and Drug benzoyl peroxide, 0.3%/2.5%) gel persons are invited to send comments
Administration, 10903 New Hampshire 6. GADAVIST (gadobutrol); EOVIST regarding this burden estimate or any
Ave., Bldg. 32, Rm. 5145, Silver Spring, (Primovist; gadoxetate disodium) other aspect of this collection of
MD 20993, 240–402–2221, 7. GENVOYA (elvitegravir, cobicistat, information, including any of the
kenneth.quinto@fda.hhs.gov. emtricitabine, and tenofovir following subjects: (1) The necessity and
alafenamide) oral tablets utility of the proposed information
SUPPLEMENTARY INFORMATION: FDA is
8. KAPVAY (clonidine extended- collection for the proper performance of
responsible for protecting the public release) tablets
health by assuring the safety, efficacy, the agency’s functions; (2) the accuracy
9. MERREM IV (meropenem for of the estimated burden; (3) ways to
and security of human and veterinary injection)
drugs, biological products, medical enhance the quality, utility, and clarity
10. NAFTIN (naftifine hydrochloride) of the information to be collected; and
devices, our Nation’s food supply, 11. NUCALA (mepolizumab)
cosmetics, and products that emit (4) the use of automated collection
12. OTIPRIO (6% ciprofloxacin otic techniques or other forms of information
radiation. suspension)
FDA is establishing a public docket, technology to minimize the information
13. PAZEO (olopatadine collection burden.
Docket No. FDA–2017–N–7022, to hydrochloride ophthalmic solution) Title of the Collection: Trafficking
receive input on post-marketing 0.7% Victim Assistance Program Social
pediatric-focused safety reviews of 14. QNASL (beclomethasone Network Analysis—Network Survey.
products posted between October 23, dipropionate) nasal aerosol Type of Collection: New.
2017, and March 16, 2018, available on 15. SAPHRIS (asenapine) OMB No. 0990–NEW-Office of the
FDA’s website at https://www.fda.gov/ 16. TIVICAY (dolutegravir) Assistant Secretary for Planning and
AdvisoryCommittees/Committees 17. TREXIMET (naproxen sodium; Evaluation–Administration for Children
MeetingMaterials/PediatricAdvisory sumatriptan succinate) and Families’ Trafficking Victim
Committee/ucm510701.htm but not 18. VALCYTE (valganciclovir) Assistance Program
presented at the March 23, 2018, PAC
meeting. FDA welcomes comments by Center for Devices and Radiological Abstract
members of the PAC, as mandated by Health The Office of the Assistant Secretary
the Best Pharmaceuticals for Children 1. FLOURISH PEDIATRIC for Planning and Evaluation (ASPE), in
Act (Pub. L. 107–109) and the Pediatric ESOPHAGEAL ATRESIA DEVICE partnership with the Administration for
Research Equity Act of 2003 (Pub. L. (HDE) Children and Families (ACF), U.S.
108–155), interested parties (such as Dated: February 28, 2018. Department of Health and Human
academic researchers, regulated Leslie Kux,
Services (HHS) is requesting Office of
industries, consortia, and patient Management and Budget (OMB)
Associate Commissioner for Policy.
groups), and the general public. The approval for a new information
[FR Doc. 2018–04400 Filed 3–2–18; 8:45 am] collection request, ‘‘Trafficking Victim
docket number is FDA–2017–N–7022.
The docket will open on March 19, BILLING CODE 4164–01–P Assistance Program (TVAP) Network
2018, and remain open until March 30, Survey.’’ ICF has been contracted to
2018. The post-marketing pediatric- carry out this project under the
focused safety reviews are for the DEPARTMENT OF HEALTH AND guidance of ASPE and ACF.
following products from the following HUMAN SERVICES TVAP, as authorized by the
centers at FDA: [Document Identifier OS–0990–New] Trafficking Victims Protection Act of
2000, provides comprehensive case
Center for Biologics Evaluation and Agency Information Collection management services to foreign-born
Research Request; 60-Day Public Comment victims of human trafficking residing in
1. EPICEL (cultured epidermal Request the United States. Since its inception,
autographs) (humanitarian device TVAP funding and infrastructure have
AGENCY: Office of the Secretary, HHS. remained relatively unchanged: Services
exemption (HDE))
2. GARDASIL 9 (Human ACTION: Notice. are paid on a per capita basis, and funds
Papillomavirus 9-valent Vaccine, are managed through three primary
SUMMARY: In compliance with the
Recombinant) grantees that enter into cooperative
requirement of the Paperwork
3. TRUMENBA (Meningococcal agreements with service providers
Reduction Act of 1995, the Office of the
Group B Vaccine) (subrecipients). Given the changing
Secretary (OS), Department of Health
landscape and the greater understanding
Center for Drug Evaluation and and Human Services, is publishing the
of the nature and extent of trafficking,
Research following summary of a proposed
HHS is undertaking a program
collection for public comment.
1. ATROPINE SULFATE assessment to understand whether any
OPHTHALMIC SOLUTION, USP DATES: Comments on the ICR must be efficiencies can be gained in the
sradovich on DSK3GMQ082PROD with NOTICES
1% received on or before May 4, 2018. program administration and structure.
2. DYMISTA (azelastine ADDRESSES: Submit your comments to Building on an earlier fiscal year 2018
hydrochloride/fluticasone Sherrette.Funn@hhs.gov or by calling assessment to solicit qualitative
propionate) 202–795–7714. feedback from a range of program
3. EDURANT (rilpivirine); FOR FURTHER INFORMATION CONTACT: stakeholders, the information collected
COMPLERA (emtricitabine, When submitting comments or for this program survey aims to help
rilpivirine, tenofovir disoproxil requesting information, please include HHS determine if efficiencies can be
VerDate Sep<11>2014 19:25 Mar 02, 2018 Jkt 244001 PO 00000 Frm 00067 Fmt 4703 Sfmt 4703 E:\FR\FM\05MRN1.SGM 05MRN1](https://thefederalregister.org/doc/83_FR_9368/page/1.svg)
![9326 Federal Register / Vol. 83, No. 43 / Monday, March 5, 2018 / Notices
gained through improved coordination network and inform recommendations or subrecipients, and type and strength
among TVAP grantees, TVAP for more efficient network management of relationships between grantees and
subrecipients, and other service and distribution of support. subrecipients. With this data, ICFwill
providers. Data will be collected through an build a social/organizational network
The data collected and analyzed electronic survey of fiscal year 2016 for HHS to depict how grantee and
under this submission will help HHS TVAP grantees and subrecipients. Key subrecipient organizations collaborate
better understand the type and extent of staff at grantee sites and subrecipient with one another through TVAP to
the relationships between the TVAP organizations will complete a self- better understand the existing network
grantees, TVAP subrecipients, and other administered online survey that will
and identify potential opportunities for
service providers operating in TVAP include questions for each respondent
improving the efficiency of the network.
subrecipient areas. This information about services for which referrals are
will enable HHS to understand the made, estimated costs of services, ASPE anticipates completion of all data
structure of the grantee/subrecipient service coordination between grantees collection activities by October 2018.
ANNUALIZED BURDEN HOUR TABLE
Number of Average
Number of responses Total burden
Forms Respondents burden per
respondents per hours
response
respondents
TVAP Network Survey ...................... TVAP grantees ................................. 3 1 45/60 2.25
TVAP Network Survey ...................... TVAP subrecipients .......................... 253 1 45/60 189.75
Total ........................................... ........................................................... 256 ........................ ........................ 192
Terry S. Clark, Programs, National Library of Medicine, NIH, NIH AIDS Study Sections, the OAR Task
Office of the Secretary, Paperwork Reduction 6705 Rockledge Drive, Suite 301, Bethesda, Force on Cost-Sharing, the FY2020 Trans-
Act Reports Clearance Officer. MD 20892–7968, 301–594–4937, huangz@ NIH Plan for HIV-Related Research, and on
[FR Doc. 2018–04386 Filed 3–2–18; 8:45 am]
mail.nih.gov. HIV/AIDS research activities from NIH
BILLING CODE 4150–05–P
(Catalogue of Federal Domestic Assistance Institutes.
Program No. 93.879, Medical Library Place: National Institutes of Health, 5601
Assistance, National Institutes of Health, Fishers Lane, Rockville, MD 20892.
HHS) Contact Person: Elizabeth S Church, Ph.D.,
DEPARTMENT OF HEALTH AND
Dated: February 27, 2018. Executive Secretary, Office of AIDS Research,
HUMAN SERVICES
DPCPSI, Office of the Director, 5601 Fishers
Michelle Trout,
National Institutes of Health Lane, Room 2E–60, Rockville, MD, 20852–
Program Analyst, Office of Federal Advisory 9830, 240–627–3201, elizabeth.church@
Committee Policy. nih.gov.
National Library of Medicine; Notice of
[FR Doc. 2018–04346 Filed 3–2–18; 8:45 am]
Closed Meetings Any interested person may file written
BILLING CODE 4140–01–P comments with the committee by forwarding
Pursuant to section 10(d) of the the statement to the Contact Person listed on
Federal Advisory Committee Act, as this notice. The statement should include the
amended, notice is hereby given of the DEPARTMENT OF HEALTH AND name, address, telephone number and when
following meeting. HUMAN SERVICES applicable, the business or professional
The meeting will be closed to the affiliation of the interested person.
public in accordance with the National Institutes of Health Information is also available on the
provisions set forth in sections Institute’s/Center’s home page:
552b(c)(4) and 552b(c)(6), Title 5 U.S.C., Office Of The Director, National www.oar.nih.gov, where an agenda and any
as amended. The grant applications and Institutes Of Health; Notice of Meeting additional information for the meeting will
the discussions could disclose Pursuant to section 10(a) of the be posted when available.
confidential trade secrets or commercial Federal Advisory Committee Act, as (Catalogue of Federal Domestic Assistance
property such as patentable materials, amended, notice is hereby given of a Program Nos. 93.14, Intramural Research
and personal information concerning meeting of the Office of AIDS Research Training Award; 93.22, Clinical Research
individuals associated with the grant Loan Repayment Program for Individuals
Advisory Council.
applications, the disclosure of which from Disadvantaged Backgrounds; 93.232,
The meeting will be open to the
would constitute a clearly unwarranted Loan Repayment Program for Research
public, with attendance limited to space Generally; 93.39, Academic Research
invasion of personal privacy. available. Individuals who plan to Enhancement Award; 93.936, NIH Acquired
Name of Committee: National Library of attend and need special assistance, such Immunodeficiency Syndrome Research Loan
Medicine Special Emphasis Panel; COI/ as sign language interpretation or other Repayment Program; 93.187, Undergraduate
Career Award. reasonable accommodations, should Scholarship Program for Individuals from
Date: March 23, 2018. notify the Contact Person listed below Disadvantaged Backgrounds, National
sradovich on DSK3GMQ082PROD with NOTICES
Time: 12:00 p.m. to 5:30 p.m. in advance of the meeting. Institutes of Health, HHS)
Agenda: To review and evaluate grant
applications. Name of Committee: Office of AIDS Dated: February 27, 2018.
Place: National Library of Medicine/Center Research Advisory Council. Natasha Copeland,
for Scientific Review, 6701 Rockledge Drive, Date: March 27, 2018.
Program Analyst, Office of Federal Advisory
Room 2141, Bethesda, MD 20892 (Virtual Time: 8:30 a.m. to 4:30 p.m.
Committee Policy.
Meeting). Agenda: OAR Director’s Report; Review of
Contact Person: Zoe E. Huang, MD, the DHHS HIV/AIDS Treatment and [FR Doc. 2018–04348 Filed 3–2–18; 8:45 am]
Scientific Review Officer, Extramural Prevention Guidelines; and, updates on the BILLING CODE 4140–01–P
VerDate Sep<11>2014 19:25 Mar 02, 2018 Jkt 244001 PO 00000 Frm 00068 Fmt 4703 Sfmt 9990 E:\FR\FM\05MRN1.SGM 05MRN1](https://thefederalregister.org/doc/83_FR_9368/page/2.svg)
Document Created: 2018-03-03 02:45:44
Document Modified: 2018-03-03 02:45:44
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Notices | |
| Action | Notice. | |
| Dates | Comments on the ICR must be received on or before May 4, 2018. | |
| Contact | When submitting comments or requesting information, please include the document identifier 0990-New-60D and project title for reference to [email protected] or call the Reports Clearance Officer. | |
| FR Citation | 83 FR 9325 |
2024 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR